Apalutamide in Patients With Metastatic Castration-Sensitive Prostate Cancer: Final Survival Analysis of the Randomized, Double-Blind, Phase III TITAN Study
Journal of clinical oncology, 2021-07, Vol.39 (20), p.JCO2003488-2303 [Peer Reviewed Journal]ISSN: 0732-183X ;EISSN: 1527-7755 ;DOI: 10.1200/JCO.20.03488 ;PMID: 33914595
Full text available